1-6 of 6
Liam Smyth
Close
Sort by
Journal Articles

Analysis of the Platelet Proteome Reveals Insights into the Pro-Inflammatory and Pro-Thrombotic State Associated with the Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

Sarah Kelliher, Fionnuala Ní Áinle, Luisa Weiss, Sara Gamba, Ella Fouhy, Marina Marchetti, Francesca Schieppati, Hayley Macleod, Kathleen Bennett, Anne Fortune, Su Wai Maung, Michael Fay, Mary Frances McMullin, Stuart Macleod, Claire Andrews, Liam Smyth, Karen Murphy, Eibhlin Conneally, Patricia Maguire, Anna Falanga, Barry Kevane
Journal: Blood
Blood (2022) 140 (Supplement 1): 2654–2655.
https://doi.org/10.1182/blood-2022-167119
Published: 2022
Journal Articles

Predictors of Healthcare Utilization in Newly Diagnosed Myeloma

Shane Toolan, MRCP, Mark Griffin, MB BCh BAO, Mark Coyne, Kate O'Mahony, BSc Pharm, Joy Lewis, Chandan D'Souza, Daniel G Connaghan, MD, Karen Murphy, MD, Kamal Fadalla, FRCPath, Joan Marie Fitzgerald, BSc, FRCPath, MBBChir, Conor Collins, Niall Swan, MRCP, MB, Crotty Tom, Gibbons David, Liam Smyth, MDFRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-138857
Published: 2020
Journal Articles

Statin and COX-2 Inhibitor Exposure Is Associated with Improved Survival in 4913 Newly Diagnosed DLBCL Patients: A Large Population Based Study

Liam Smyth, MDFRCPath, Danielle N. Blunt, BMBS, Evgenia Gatov, Chenthila Nagamuthu, MPH, Ruth Croxford, MSc, Lee Mozessohn, MD, Matthew Cheung, MDMSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3476.
https://doi.org/10.1182/blood-2019-127156
Published: 2019
Journal Articles

Combination of DPX-Survivac, Low Dose Cyclophosphamide, and Pembrolizumab in Recurrent/Refractory DLBCL: The Spirel Study

Neil L Berinstein, MD, Isabelle Bence-Bruckler, MD, Pierre Laneuville, MD FRCPC, Douglas A. Stewart, MD, Nicholas Allen Forward, MDMSc,FRCPC, Liam Smyth, MDFRCPath, Gail Klein, MSc, Nancy Pennell, BSc, Kim Roos, BA, BSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 3236.
https://doi.org/10.1182/blood-2019-125963
Published: 2019
Journal Articles

Diagnosis to Treatment Interval in DLBCL Is Predictive of Overall Survival in a Large, Population-Based Registry

Danielle N. Blunt, BMBS, Liam Smyth, MD FRCPath, Evgenia Gatov, Chenthila Nagamuthu, MPH, Rena Buckstein, MD FRCPC, Ruth Croxford, MSc, Matthew Cheung, MD MS, FRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 1700.
https://doi.org/10.1182/blood-2018-99-120313
Published: 2018
Journal Articles

Prolonged Molecular and Clinical Remissions in Follicular Lymphoma Patients Treated with HDT/ASCT and Combination Immunotherapy with Rituximab and Interferon α

Liam Smyth, MD FRCPath, Rena Buckstein, MD FRCPC, Pennell Nancy, BSc, Rashmi Weerasinghe, Matthew Cheung, MD MS, FRCP, Eugenia Piliotis, MD FRCP, MD, Kevin Imrie, MD, David Spaner, MD PhD, Marciano D. Reis, MD, Lisa Chodirker, MD, Zeina Ghorab, Violet ruth,nancy Milliken, Angela Boudreau, RN, BScN, MN, CON(C), Neil Berinstein, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4069.
https://doi.org/10.1182/blood.V130.Suppl_1.4069.4069
Published: 2017